
Wacker Biotech Partners with RNAV8 Bio to Advance mRNA Therapeutics Innovation
Wacker Biotech, a globally recognized contract development and manufacturing organization (CDMO) and a wholly owned subsidiary of Wacker Chemie AG, has officially entered into a strategic collaboration with RNAV8 Bio, a Boston-based biotechnology company specializing in mRNA engineering. This partnership…